262 related articles for article (PubMed ID: 1402661)
21. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals.
Ranga U; Woffendin C; Verma S; Xu L; June CH; Bishop DK; Nabel GJ
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1201-6. PubMed ID: 9448309
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
[TBL] [Abstract][Full Text] [Related]
23. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
Wu BY; Woffendin C; Duckett CS; Ohno T; Nabel GJ
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1480-4. PubMed ID: 7878004
[TBL] [Abstract][Full Text] [Related]
24. Exchange of functional domains between Rev proteins of HIV-1 and SIVmac239 results in a dominant negative phenotype.
Berchtold S; Ries J; Hornung U; Aepinus C
Virology; 1994 Oct; 204(1):436-41. PubMed ID: 8091675
[TBL] [Abstract][Full Text] [Related]
25. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
Smith C; Lee SW; Wong E; Gallardo H; Page K; Gaspar O; Lebkowski J; Gilboa E
Antiviral Res; 1996 Oct; 32(2):99-115. PubMed ID: 8891169
[TBL] [Abstract][Full Text] [Related]
26. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
Coburn GA; Cullen BR
J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
[TBL] [Abstract][Full Text] [Related]
28. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
29. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
Bogerd H; Greene WC
J Virol; 1993 May; 67(5):2496-502. PubMed ID: 8474155
[TBL] [Abstract][Full Text] [Related]
30. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
31. Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA.
Zolotukhin AS; Harford JB; Felber BK
Nucleic Acids Res; 1994 Nov; 22(22):4725-32. PubMed ID: 7984424
[TBL] [Abstract][Full Text] [Related]
32. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
33. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
35. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
[TBL] [Abstract][Full Text] [Related]
36. Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.
Wu BY; Woffendin C; MacLachlan I; Nabel GJ
J Virol; 1997 Apr; 71(4):3161-7. PubMed ID: 9060679
[TBL] [Abstract][Full Text] [Related]
37. Genetic vaccination-induced immune responses to the human immunodeficiency virus protein Rev: emergence of the interleukin 2-producing helper T lymphocyte.
Chan SY; Louie MC; Piccotti JR; Iyer G; Ling X; Yang ZY; Nabel GJ; Bishop DK
Hum Gene Ther; 1998 Oct; 9(15):2187-96. PubMed ID: 9794203
[TBL] [Abstract][Full Text] [Related]
38. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
[TBL] [Abstract][Full Text] [Related]
39. Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.
Ranga U; Woffendin C; Yang ZY; Xu L; Verma S; Littman DR; Nabel GJ
J Virol; 1997 Sep; 71(9):7020-9. PubMed ID: 9261432
[TBL] [Abstract][Full Text] [Related]
40. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.
Szilvay AM; Bøe SO; Kalland KH
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1965-1974. PubMed ID: 10466792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
